| Application no. and date | 05757842.9 (espacenet) (Federated) (European Patent Register), 20050706 | | Patent/reg. no. and date | DK/EP 1817051, 20150225 | | Publication date | 20070815 | | Priority no. and date | GB 0415491, 20040712 | | EP pub. no. and date |
EP 1817051 20070815 | | Effective date | | | Applicant/owner | Ipsen Biopharm Limited, Ash Road,
Wrexham Industrial Estate,
Wrexham LL13 9UF, GB | | Applicant ref. no. | P232677DKEP | | Inventor | WEBB, Paul, Ipsen Biopharm
Unit 9, Ash Road
Wrexham Industrial Estate
Wrexham LL13 9UF, GB,
WHITE, Mary, Ipsen Biopharm
Unit 9, Ash Road
Wrexham Industrial Estate
Wrexham LL13 9UF, GB,
PARTINGTON, Julie, Ipsen Biopharm
Unit 9, Ash Road,
Wrexham Industrial Estate
Wrexham LL13 9UF, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/48 (2006.01) , A61K 47/30 (2006.01) | | Title | Farmaceutiske sammensætninger, der omfatter botulinum-neurotoksin, et ikke-ionisk overfladeaktivt stof, natriumchlorid og saccharose | | Int. application no. | GB2005002653 | | Int. publication no. | WO2006005910 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
